Core Insights - The SIA2025 China Scientific Skincare Innovation Alliance Annual Summit was held in Shanghai, focusing on the transformation of the skincare industry from "single-point efficacy" to "holistic solutions" [1] - The summit highlighted the release of the "2025 China Medical Skincare Clinical Insight Report" and a strategic cooperation agreement between SIA and Meichuangjingjie, marking a new phase in the "medical-research co-creation" ecosystem [1] Industry Overview - The Chinese cosmetics market has surpassed 500 billion yuan, with the efficacy skincare segment continuing to expand [1] - The industry faces challenges such as a lack of evidence-based claims, insufficient consumer education, and a fragmented results transformation chain [1] Expert Insights - Professor Li Bin emphasized that the skincare health industry is a "rapidly developing new industry," with increasing consumer demand for suitable skincare products [3] - He noted the importance of professional medical evaluation in skincare product selection and the role of SIA in integrating enterprise research and medical expertise [3] Product Development and Market Dynamics - Chang Jiang pointed out the fast iteration of domestic cosmetic products but criticized the insufficient brand accumulation, suggesting that international brands maintain core ingredients and brand value over time [4] - He argued that frequent product changes can mislead consumers, especially those with sensitive skin, who benefit from stable product choices [4] - Professor Li further analyzed that the Chinese skincare market lacks internationally influential local brands and will undergo a "survival of the fittest" process, emphasizing the need for differentiated products that meet diverse consumer needs [4] Capital and Innovation - Cai Zhongxi highlighted that rapid iteration is partly a result of market marketing, stressing the need for genuine product innovation rather than superficial updates [4] - He mentioned the importance of the SIA platform in promoting scientific skincare concepts to help consumers make informed choices [4] Research and Industry Integration - The SIA aims to make professional expertise visible through three main tasks: collaborative research, results transformation, and scientific communication [5] - The "SIA100" evaluation system is designed to independently assess product efficacy and scientific validity, enhancing product credibility [5] - The collaboration with capital partners aims to identify potential unicorn companies in the skincare industry, showcasing their value [5] Clinical and Research Collaboration - The Shanghai Dermatology Hospital's establishment of a cosmetics professional committee aims to bridge communication between doctors and enterprises, aligning product development with clinical needs [6] - This collaboration is seen as a crucial pathway for future medical-research co-creation [6]

Core Viewpoint - The functional cosmetics market is experiencing rapid growth, with a compound annual growth rate (CAGR) of 36.03% from 2021 to 2025, expected to expand from 30.8 billion yuan to 105.4 billion yuan, which is ten times the growth rate of the overall cosmetics market [28] Group 1: Industry Challenges - The functional skincare market is currently facing significant challenges, including a mismatch between supply and consumer demand, insufficient scientific evidence, and a disconnect between medical research and industry practices [7][9] - There is a notable lack of consumer awareness regarding scientific skincare, which has not kept pace with advancements in the medical field [8] - The industry has been criticized for relying on popular trends rather than scientific principles, leading to products that lack robust scientific backing [9] Group 2: Medical-Research Collaboration - The concept of "medical-research collaboration" is emerging as a necessary trend in the industry, driven by the need to integrate medical insights, scientific research, and industrial capabilities [10][12] - This collaboration is essential for developing effective, safe, and scientifically validated functional skincare products [12][21] - The integration of medical definitions of skin issues, research hypotheses, and industrial application is crucial for creating a reliable product system [21] Group 3: Company Initiatives - Leibao Pharmaceutical Technology (Shanghai) Co., Ltd. has been a pioneer in the "medical-research collaboration" approach since its establishment in 2003, focusing on the scientific basis of skincare products [13][14] - The company has developed a comprehensive technical supply chain that includes active ingredient development, formulation technology, and product safety and efficacy testing [19] - Leibao has established partnerships with numerous hospitals and experts to enhance its research capabilities and product development [15][25] Group 4: Product Development and Innovation - The company has successfully launched products based on clinical consensus and scientific research, such as the "Itch Relief Soothing Body Lotion," which addresses atopic dermatitis through a scientifically designed formula [22] - Leibao's commitment to scientific rigor and evidence-based product development is reflected in its numerous patents and research achievements [19][27] - The company aims to shift the industry towards a model where scientific validation is the foundation of product efficacy, moving away from reliance on marketing [27]

Core Insights - The beauty industry is undergoing a technological transformation, with the integration of medical research driving value upgrades in cosmetics. This dual integration of medicine and beauty is defining a new competitive logic in the industry [3][6][24]. Industry Trends - The 20th China Dermatology Association (CDA) conference showcased over 10,000 dermatologists and more than 100 companies, including both domestic and international beauty brands, highlighting the industry's focus on scientific collaboration [3][4]. - The concept of "medical-research co-creation" emerged as a key theme, with brands actively participating in discussions on how to contribute to the skin science system, moving from mere users of research to active participants in scientific understanding and industry standards [7][24]. Brand Innovations - Winona, a brand known for its scientific foundation, showcased its "NUTE" principle at CDA 2025, which emphasizes clinical needs, unique mechanisms, technology empowerment, and credible evidence in product development [10]. - HBN, a domestic skincare brand, initiated the establishment of a group standard for "Cosmetic Efficacy Evidence Weight Assessment Guidelines," aiming to shift the industry from experience-driven to evidence-based competition [11][13]. - Estee Lauder's Clinique presented a white paper on the causes and distribution patterns of post-inflammatory hyperpigmentation, demonstrating the brand's commitment to scientific validation [14][16]. Research and Development - The integration of research and clinical application is evident in the initiatives taken by brands like Giant Bio and Zhenyan Bio, which are expanding the boundaries of medical-research co-creation through innovative collagen products and clinical studies [20][22]. - The collaboration between brands and medical experts is evolving, with companies like Ximu Yuan conducting extensive research on sensitive skin, showcasing a shift from being mere users of research to contributors to scientific inquiry [24][25]. Future Outlook - The CDA conference highlighted a significant shift in the beauty industry towards a more scientific and collaborative approach, with brands, medical institutions, and research organizations forming a new ecosystem that emphasizes shared data and mutual advancement [47][48]. - The focus on original ingredient research is becoming a core strategy for leading domestic brands, as they aim to differentiate themselves from homogenized competition [38][39].

Core Viewpoint - The beauty industry is experiencing a significant shift towards "cross-border" integration, with brands attempting to merge pharmaceuticals, cosmetics, and medical devices to break traditional growth boundaries. However, many companies struggle to genuinely overcome professional barriers, leading to a crisis of trust among consumers due to a lack of verifiable scientific results and a coherent innovation framework [4][5][6]. Group 1: Industry Challenges - The concept of "cross-border" has become prevalent in the cosmetics industry, but many companies have not effectively crossed professional barriers, resulting in a disconnect between marketing concepts and actual innovation [4][5]. - The effectiveness-driven skincare market has reached a bottleneck, characterized by formula homogenization and vague efficacy claims, leading to increased consumer skepticism [4][5]. - The inherent cultural and operational differences between pharmaceutical, cosmetic, and medical device companies create challenges in cross-border collaboration, often resulting in organizational inefficiencies [5]. Group 2: Proposed Solutions - The SIA 2025 Scientific Skincare Innovation Alliance Conference aims to address these challenges by promoting a concept of "professional without boundaries," facilitating the free flow of knowledge, technology, and resources across professional domains [6][7]. - The conference seeks to establish a collaborative platform that integrates scientific rigor with commercial viability, moving the industry from fragmented discussions to a consensus-driven approach [7][8]. - SIA plans to implement a comprehensive system that connects scientific insights with practical applications, ensuring that research translates into market validation and sustainable growth [7][8]. Group 3: Conference Structure and Focus - The SIA conference will feature a structured agenda, including a main forum and specialized sessions, focusing on three breakthroughs: transitioning from concepts to ecological implementation, enhancing content depth, and improving operational efficiency [8][20]. - The conference will release the first "China Hair Industry Map," providing a scientific framework for the hair health sector and establishing a practical sample for the skincare industry [21]. - A "Future 100" list will be published to identify high-potential companies, facilitating their visibility and investment opportunities, thereby enhancing their growth trajectories [22][24]. Group 4: Long-term Vision - The SIA conference represents a systemic upgrade for the skincare industry, aiming to create a new infrastructure that effectively translates professional insights into market validation [77]. - By fostering a complete value cycle from scientific research to market application, SIA aims to enhance industry efficiency and build genuine international competitiveness for Chinese brands [77]. - The overarching theme of "Beauty Cross-Border, Professional Without Boundaries" signifies a call for a sustainable and evolving ecological community within the skincare industry [77].

Core Viewpoint - The article emphasizes the importance of developing a star ingredient in the Chinese market, where domestic brands are shifting from relying on traffic to building trust through self-researched key ingredients, focusing on precise care, high cost-effectiveness, and scientific backing [2][3][8]. Market Trends - The maturity of ingredient-focused consumers is leading to higher expectations for clinical validation, suitability for local skin types, and research history of ingredients [2]. - The traditional market logic of foreign brands, where "star ingredients equal strong brands," is being rewritten as domestic brands build cultural and technological confidence through rigorous research [3][8]. Brand Development - Domestic brands are focusing on creating "super brands" before developing star ingredients, which is crucial for their self-researched ingredients to gain prominence [6]. - The brand "Zhenyan" has established a strong professional image in the skincare market by integrating biotechnology and rigorous medical research, gaining recognition from over 500 dermatology professionals and being a top choice among clinical selections [6][8]. Ingredient Innovation - Zhenyan has successfully achieved large-scale production of recombinant mussel adhesive protein, overcoming previous challenges related to sourcing and environmental concerns [10][12]. - The unique properties of mussel adhesive protein, such as its high adhesion and film-forming capabilities, have been recognized in top scientific journals, establishing its efficacy in medical and academic circles [10][12]. Research and Development - Zhenyan has conducted over 1500 human efficacy validations for the recombinant mussel adhesive protein, confirming its rapid repair capabilities [12][15]. - The company has developed a comprehensive research and clinical verification system, collaborating with authoritative institutions to validate the efficacy of its products [15][17]. Market Performance - The Zhenyan Rapid Repair Essence, featuring recombinant mussel adhesive protein, has seen significant market success, selling over 16,000 bottles during the 2024 Double 11 shopping festival and achieving a 160% increase in sales during the 2025 618 event [27][29]. Strategic Positioning - Zhenyan is leveraging its technological breakthroughs to lead the market in the application of recombinant mussel adhesive protein, establishing itself as a leader in this emerging field [17][18]. - The brand's approach represents a strategic shift from marketing-driven to research-driven development, which is essential for long-term brand value and maturity in the domestic market [32].

Core Viewpoint - The article emphasizes that Proya is advancing its globalization strategy and gaining recognition in the international beauty market through a focus on technological innovation and long-term commitment [3][4]. Group 1: Globalization Strategy - Proya is positioned as China's first 10 billion beauty company, steadily progressing in its globalization strategy and establishing a presence in the global beauty technology forefront [4]. - The company showcased its global innovation strategy and latest research achievements at the Cosmetic 360 exhibition, signaling its commitment to international expansion [4][5]. Group 2: Technological Innovation - Proya has developed an AI-driven SaaS platform that provides comprehensive solutions for the cosmetics industry, significantly shortening R&D cycles and reducing trial-and-error costs [6]. - The company has integrated AI technology to enhance efficiency in product development, achieving a 50% increase in overall efficiency through the analysis of vast amounts of research literature [8]. Group 3: Research and Development - Proya has established a global R&D framework, including centers in Hangzhou, Shanghai, and Europe, focusing on basic research, application research, and clinical studies [20][21]. - The company has a dedicated team of 389 R&D personnel and has obtained 240 authorized patents, reinforcing its technological capabilities in key areas such as skin anti-aging and green materials [23]. Group 4: Product Innovation - Proya's Ruby Series 3.0, featuring the patented peptide ingredient "Peptide-161," represents a significant breakthrough in anti-aging ingredients, having been approved by the National Medical Products Administration [13][14]. - The Off&Relax series introduces advanced technologies for scalp care, including high molecular magnetic technology to effectively combat harmful bacteria [13]. Group 5: Future Outlook - Proya aims to rank among the top ten global cosmetics companies within the next decade, driven by its dual focus on consumer insights and global technological collaboration [23]. - The company's participation in major international events reflects its strategic positioning and commitment to innovation in the global beauty industry [19].

Core Insights - The beauty and personal care industry is transitioning from rapid growth to a focus on meticulous development, emphasizing research and innovation over marketing and distribution [1][3] Company Strategy - Betaini Group has formed a strategic partnership with Lumenis Group to enhance the home beauty device brand Tripollar in the Chinese market, focusing on deep operation and product innovation [1][3] - The collaboration is a significant step in extending the "medical-research co-creation" concept into the home beauty sector, leveraging over 20 years of skin science research and product development experience [3][4] Product Development - The core value of beauty devices lies in their safety and effectiveness, necessitating a deep integration of medical-grade technology and skin science [4] - Betaini is conducting clinical research to address the needs of Chinese consumers, particularly in sensitive skin anti-aging, optimizing energy parameters and waveform design to minimize potential irritation [4] - The Tripollar brand will evolve towards an integrated value proposition of "technology + scenario + service," transitioning from standalone devices to comprehensive solutions that include devices, specialized skincare essences, and online consultation services [4][6] Market Positioning - The home beauty device segment aligns with Betaini's mission to create a skin health ecosystem in China, focusing on high-tech and high-user engagement areas for sustainable development [6] - The company aims to redefine the home skin beauty industry through continuous investment and open collaboration, emphasizing the importance of creating trends rather than merely chasing them [6]

Core Viewpoint - The growing consumer demand for a better quality of life is driving the upgrade of the consumption industry, particularly in the beauty and personal care sector, where competition is shifting from marketing to research and innovation [1] Group 1: Strategic Collaboration - Betaini Group has formed a strategic partnership with Lumenis Group to advance the home beauty device brand Tripollar in the Chinese market, focusing on deep operation and product innovation [1][2] - The collaboration aims to extend the "medical-research co-creation" concept into home beauty, integrating home devices with Betaini's professional skincare products to provide consumers with advanced anti-aging solutions [2][3] Group 2: Technological Innovation - Betaini emphasizes technological innovation as a core driver for sustainable development, leveraging research platforms in various locations, including China and abroad, to create a global research ecosystem [2] - The partnership with Lumenis, which holds over 500 self-developed patents and extensive clinical literature, aims to transform professional medical technology into efficient and convenient home applications [3] Group 3: Product Development - Tripollar is shifting from a focus on hardware specifications to an integrated value proposition of technology, scenarios, and services, moving towards a system solution that combines devices, specialized skincare, and online consultation services [4] - The brand plans to address consumer pain points by introducing a "light care mode" suitable for fast-paced lifestyles, offering personalized usage suggestions and effect tracking [4] Group 4: Market Positioning - Betaini's operational strategy for Tripollar aligns with its overall direction, focusing on high-quality sustainable development by expanding into technology-driven and user-engaging sectors [5] - The home beauty device market is transitioning from marketing-driven growth to a phase where technological strength, clinical validation, and user experience are key drivers [5] Group 5: Future Outlook - Betaini intends to deepen its R&D collaboration with Lumenis, aiming to redefine the home skincare beauty industry and create trends rather than merely following them [6] - The company is exploring the integration of international leading technologies with Chinese skincare science, which not only opens new growth avenues for itself but also contributes to elevating the Chinese beauty industry on the global value chain [7]

Core Viewpoint - The article emphasizes the trend of "medical-research co-creation" in the domestic beauty industry, highlighting that while this concept is gaining traction, it is still in its infancy in China, lacking clear implementation standards. The German skincare brand Eucerin has set a precedent with its comprehensive approach to medical-research co-creation over its 125-year history [3][6]. Group 1: Eucerin's Achievements - Eucerin showcased its advancements at the 34th European Academy of Dermatology and Venereology (EADV) with three thematic satellite sessions and 18 academic posters, particularly highlighting the publication of the "International Consensus on Pigment Management," which includes the patented ingredient Thiamidol® in global treatment recommendations [4][24]. - Eucerin's practice serves as a practical guide for the Chinese beauty industry, demonstrating a successful model of medical-research co-creation [6][21]. - The brand has built a robust medical-research co-creation system, which is recognized as a competitive advantage, rooted in its unique scientific brand heritage established in 1900 [7][11]. Group 2: Research and Development - Eucerin has established a standard medical-research co-creation pathway consisting of clinical insights, product development, and efficacy evaluation, successfully navigating these core stages [12][16]. - The brand collaborates closely with thousands of dermatology experts globally and holds over 1,500 effective patents, investing more than €200 million annually in research and development [16][38]. - The efficacy of Thiamidol® has been validated through over 120 clinical studies involving more than 9,000 participants across 28 countries, proving its effectiveness for all skin types [16][29]. Group 3: Localization in China - Eucerin has effectively localized its medical-research co-creation model in China, launching the second-generation Eucerin Brightening Essence with dual certifications for "whitening" and "new ingredient registration" [19][40]. - The product development involved extensive collaboration with local dermatologists and consumer research, addressing the specific needs of Chinese consumers [19][42]. - Eucerin's innovative "Red-Brown-Black" pigment management strategy systematically addresses pigmentation issues, showcasing its commitment to localized solutions [19][21]. Group 4: Market Performance - The functional skincare market in China is rapidly growing, with the market size increasing from ¥7.42 billion in 2016 to ¥48 billion in 2024, indicating a competitive landscape [37]. - Eucerin achieved a remarkable 61.9% organic sales growth in the Chinese market in the first half of the year, significantly outperforming expectations [38][39]. - The brand's success is attributed to its comprehensive strategy, including expanding its target audience, localized R&D, entering the medical aesthetics sector, and enhancing brand communication [38][40][42]. Group 5: Academic Contributions - Eucerin's participation in the EADV conference included the release of the "International Consensus on Pigment Management," which provides a unified standard for diagnosing and treating common pigmentary disorders [27][30]. - The brand's focus on skin microbiome and anti-aging breakthroughs was highlighted in discussions led by global experts, emphasizing the importance of integrating skin science with clinical practice [30][31]. - Eucerin's product matrix, particularly its anti-pigment series, received significant attention, showcasing its commitment to evidence-based solutions in clinical and daily skincare [32][35]. Group 6: Future Outlook - Eucerin's trajectory from a German pharmacy to a prominent player on the international academic stage exemplifies the successful implementation of medical-research co-creation in the beauty industry [44]. - The brand's long-term commitment to research and development, combined with its strategic focus on the Chinese market, positions it to lead industry trends and innovations [44].

Core Viewpoint - The Chinese cosmetics market is transitioning from high-speed growth to a "new normal" of high-quality development, presenting challenges for companies like Betaini, which must demonstrate strategic resilience and future potential amid a more competitive landscape [1] Financial Performance - In the first half of 2025, Betaini reported revenue of 2.372 billion yuan and a net profit attributable to shareholders of 247 million yuan, with a non-recurring net profit of 183 million yuan, indicating pressure on revenue and profitability due to a challenging consumption environment and strategic adjustments [1][5] - The overall gross margin for the company was 76.0%, an increase of 3.4 percentage points year-on-year, while the net profit margin was 10.4%, a decrease of 6.8 percentage points year-on-year, reflecting the impact of product structure optimization and promotional strategy adjustments [5] Product and Category Analysis - Skincare products generated revenue of 2.001 billion yuan, makeup products 239 million yuan, and medical devices 116 million yuan, with the main brand Winona accounting for 82.2% of total revenue [3] - Betaini focuses on developing products for sensitive skin, covering various areas such as soothing, sun protection, whitening, anti-aging, and acne treatment, with new product launches reinforcing its technological backing [3][9] Channel Strategy - Online channel revenue was 1.743 billion yuan, with a year-on-year decline of only 5.9%, indicating strong operational resilience, while offline distribution revenue was 424 million yuan [3][12] - The company is shifting its channel strategy from broad traffic acquisition to deep user engagement, enhancing its online operations through refined membership systems and private domain traffic management [12] Market Trends and Consumer Behavior - The cosmetics industry is experiencing stricter regulations and a shift towards high-quality development, with changing consumer behaviors emphasizing ingredient transparency, rational consumption, and confidence in domestic brands [7][8] - Betaini's "1+N" brand strategy is under scrutiny, as the growth of its main brand Winona and the speed of new brand incubation will determine the company's future potential [8][9] Research and Development - The company continues to invest in research on active ingredients from Yunnan's unique plants, enhancing extraction processes and foundational research to build barriers around these ingredients [11] - Collaborations with dermatology hospitals are expanding, providing robust clinical data support for new product launches, which strengthens the efficacy and safety claims of its products [11]